Sort   by:  
 Page size 
UnknownExposure-safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug-resistant tuberculosis.
Not available
S-EPMC8674006 | biostudies-literature
UnknownTranslational population target binding model for the anti-FcRn fragment antibody efgartigimod.
Not available
S-EPMC11621151 | biostudies-literature
UnknownA Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
Not available
S-EPMC6021660 | biostudies-literature
UnknownPopulation Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study.
Not available
S-EPMC8518967 | biostudies-literature
UnknownUsing Model-Based "Learn and Confirm" to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial.
Not available
S-EPMC5270295 | biostudies-literature
UnknownPopulation pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes.
Not available
S-EPMC3394132 | biostudies-literature
UnknownBedaquiline for multidrug-resistant TB in paediatric patients.
Not available
S-EPMC8412106 | biostudies-literature
UnknownA Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study.
Not available
S-EPMC9373154 | biostudies-literature
Sort   by:  
 Page size